Puma Biotechnology (PBYI) Q1 Earnings: Stock to Disappoint?
Goldman Sachs Group Cuts Stake in Puma Biotechnology (PBYI)
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
Puma Biotechnology, Inc.'s (NASDAQ:PBYI) US$24m market value fall may be overlooked by institutional investors after a year of 1.6% returns - Simply Wall St News
Puma Biotechnology Stock (NASDAQ:PBYI), Quotes and News Summary - Benzinga